Seattle Genetics begins Phase II trial of Adcetris to treat lupus
In lupus, the body’s own immune system overreacts and attacks healthy organs, causing inflammation, pain, permanent organ damage or death. Adcetris is directed to CD30, which is expressed
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.